Article
Transient treatment exclusively containing nucleoside analogue reverse transcriptase inhibitors in highly antiretroviral-experienced patients preserves viral benefit when a fully active therapy was initiated.
HIV clinical trials - 1 Jan 2000
Bonjoch A, Buzon M J, Llibre J M, Negredo E, Puig J, Pérez-Alvarez N, Videla S, Martinez-Picado J, Clotet B
Abstract excerpt
BACKGROUND: We determined whether coformulated zidovudine/lamivudine/abacavir plus tenofovir could maintain immune status in comparison with a genotype-guided salvage regimen in highly pretreated patients. METHOD: This was a randomized pilot control-arm study. The primary endpoint was the proport...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.